Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 | P41231 | 8/20 | 0.58 |
| ▸ | UMPS | P11172 | 4/20 | 0.58 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.52 |
| ▸ | P2RY6 | Q15077 | 6/20 | 0.50 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.49 |
| ▸ | P2RY4 | P51582 | 3/20 | 0.49 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Orotidine Monophosphate SCHEMBL12727823 | 1.00 | P2RY2 (0.58) | P2RY2UMPSDNPH1P2RY6P2RX3 | |
| Orotidine Monophosphate SCHEMBL30969958 | 0.99 | P2RY2 (0.57) | P2RY2UMPSDNPH1P2RY6P2RX3 | |
| Orotidine Monophosphate SCHEMBL20266267 | 0.99 | P2RY2 (0.57) | P2RY2UMPSDNPH1P2RY6P2RX3 | |
| SCHEMBL18453338 | 0.92 | P2RY2 (0.70) | P2RY2P2RY6P2RX3P2RY4P2RY14 | |
| SCHEMBL1398653 | 0.92 | P2RY2 (0.54) | P2RY2UMPSDNPH1P2RY6P2RX3 | |
| SCHEMBL3514478 | 0.90 | P2RY2 (0.73) | P2RY2P2RY6P2RX3P2RY4P2RY14 | |
| SCHEMBL1363155 | 0.89 | P2RY2 (0.60) | P2RY2UMPSDNPH1P2RY6P2RY4 | |
| SCHEMBL12143856 | 0.89 | P2RY2 (0.60) | P2RY2UMPSDNPH1P2RY6P2RY4 | |
| SCHEMBL12143130 | 0.89 | P2RY2 (0.60) | P2RY2UMPSDNPH1P2RY6P2RY4 | |
| SCHEMBL12143135 | 0.87 | UMPS (0.58) | P2RY2UMPSDNPH1P2RY6P2RY4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2211 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250313852-A1 | BIDIRECTIONAL CHEF1 VECTORS | AGC BIOLOGICS INC (US) | 2025-10-09 | — | — | US | claimed |
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | TEAM MEDICAL, LLC | 2025-09-18 | — | — | US | claimed |
| US-20250145981-A1 | CHEMOENZYMATIC CARBOXYLATION COMPOSITIONS AND METHODS | SOLUGEN, INC. (US) | 2025-05-08 | — | — | US | claimed |
| CN-119432702-A | Uracil producing strain, construction method and application thereof | 新疆瑞诺生物科技有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-118620816-B | Uridine producing strain, construction method and application thereof | 天津科技大学 | 2024-10-29 | — | — | CN | claimed |
| CN-118620816-A | Uridine producing strain, construction method and application thereof | 天津科技大学 | 2024-09-10 | — | — | CN | claimed |
| CN-118272285-B | Uracil nucleotide production strain, directional transformation method and application thereof | 天津科技大学 | 2024-08-16 | — | — | CN | claimed |
| CN-118302514-A | Acid-resistant yeast strain for high yield of L-malic acid, construction method and application thereof | 中国科学院天津工业生物技术研究所 | 2024-07-05 | — | — | CN | claimed |
| CN-118272285-A | Uracil nucleotide production strain, directional transformation method and application thereof | 天津科技大学 | 2024-07-02 | — | — | CN | claimed |
| CN-117467551-A | Acid-resistant yeast strain for high yield of L-malic acid, construction method and application thereof | 中国科学院天津工业生物技术研究所 | 2024-01-30 | — | — | CN | claimed |
| US-20030158140-A1 | Splicing as target for identifying new active substances | BAYER AKTIENGESELLSCHAFT (DE) | 2003-08-21 | — | — | US | claimed |
| EP-1325959-A1 | TRANSFORMATION SYSTEM OF FUNGUS BELONGING TO THE GENUS MONASCUS | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2003-07-09 | — | — | EP | claimed |
| EP-1255567-A1 | SELECTIVE CELLULAR TARGETING: MULTIFUNCTIONAL DELIVERY VEHICLES | Drug Innovation & Design, Inc. (US) | 2002-11-13 | — | — | EP | claimed |
| WO-2001077366-A1 | POSITIVE SELECTION METHOD, COMPOUNDS, HOST CELLS AND USES THEREOF | CUBIST PHARMACEUTICALS, INC. (US) | 2001-10-18 | — | — | WO | claimed |
| WO-2001036003-A2 | SELECTIVE CELLULAR TARGETING: MULTIFUNCTIONAL DELIVERY VEHICLES | DRUG INNOVATION & DESIGN, INC. (US) | 2001-05-25 | — | — | WO | claimed |
| EP-0504279-B1 | FERMENTATION PROCESS FOR THE PRODUCTION OF PYRIMIDINE DEOXYRIBONUCLEOSIDES | CHEMGEN CORP (US) | 1997-07-09 | — | — | EP | claimed |
| US-5213972-A | Production of thymidine and deoxyuridine, intermediates for AZT | CHEMGEN CORPORATION (US) | 1993-05-25 | — | — | US | claimed |
| EP-0504279-A4 | FERMENTATION PROCESS FOR THE PRODUCTION OF PYRIMIDINE DEOXYRIBONUCLEOSIDES | — | 1993-02-17 | — | — | EP | claimed |
| EP-0504279-A1 | FERMENTATION PROCESS FOR THE PRODUCTION OF PYRIMIDINE DEOXYRIBONUCLEOSIDES. | CHEMGEN CORP (US) | 1992-09-23 | — | — | EP | claimed |
| WO-1991009130-A1 | FERMENTATION PROCESS FOR THE PRODUCTION OF PYRIMIDINE DEOXYRIBONUCLEOSIDES | CHEMGEN CORPORATION (US) | 1991-06-27 | — | — | WO | claimed |